Charles Schwab’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $10.7M | Sell |
|
|||||
|
2020
Q4 | $5.37M | Buy |
|
|||||
|
2020
Q3 | $1.33M | Buy |
|
|||||
|
2020
Q2 | $1.3M | Sell |
|
|||||
|
2020
Q1 | $488K | Buy |
|
|||||
|
2019
Q4 | $973K | Sell |
|
|||||
|
2019
Q3 | $845K | Buy |
|
|||||
|
2019
Q2 | $1.12M | Sell |
|
|||||
|
2019
Q1 | $2.73M | Buy |
|
|||||
|
2018
Q4 | $1.75M | Sell |
|
|||||
|
2018
Q3 | $2.65M | Buy |
|
|||||
|
2018
Q2 | $2.78M | Buy |
|
|||||
|
2018
Q1 | $2.63M | Buy |
|
|||||
|
2017
Q4 | $2.84M | Sell |
|
|||||
|
2017
Q3 | $5.76M | Buy |
|
|||||
|
2017
Q2 | $3.37M | Sell |
|
|||||
|
2017
Q1 | $4.43M | Sell |
|
|||||
|
2016
Q4 | $10.3M | Sell |
|
|||||
|
2016
Q3 | $11.4M | Buy |
|
|||||
|
2016
Q2 | $5.96M | Buy |
|
|||||
|
2016
Q1 | $1.85M | Buy |
|
|||||
|
2015
Q4 | $1.76M | Buy |
|
|||||
|
2015
Q3 | $513K | Hold |
|
|||||
|
2015
Q2 | $828K | Hold |
|
|||||
|
2015
Q1 | $761K | Buy |
|
|||||
|
2014
Q4 | $684K | Hold |
|
|||||
|
2014
Q3 | $297K | Hold |
|
|||||
|
2014
Q2 | $394K | Buy |
|